SIK2 and breast carcinoma: To determine if SIK2 affects cancer cell motility, siRNA transfection was used to deplete SIK2 in ovarian cancer cell lines (SKOV3 and OVCAR8) and breast cancer cell lines (MDA‐MB‐231 and Hs578t).